HR-4697 : Still Just a Bill

Prevent Drug Addiction Act of 2016

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants for consumer education about opioid addiction. (Opioids are drugs with effects similar to opium, such as heroin or certain prescription painkillers.)

This bill amends the Controlled Substances Act to require medical practitioners to be trained in the treatment of opioid-dependent patients, pain management, and early detection of opioid addiction before they can be registered by the Drug Enforcement Administration to dispense opioids.

Opioid treatment programs that close on any day must make arrangements for each patient to receive treatment during the closure, as necessary.

A report must be submitted to SAMHSA for each individual who dies while receiving treatment in an opioid treatment program. In states receiving funding for controlled substance monitoring programs, deaths where an opioid drug is detected in the body must be reported to SAMHSA.

The National Center for Health Statistics of the Centers for Disease Control and Prevention must establish a National Opioid Death Registry to track opioid-related deaths.

The Agency for Healthcare Research and Quality must develop and apply prescription drug addiction prevention and treatment quality measures.

This bill amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to allow prescription drug plan (PDP) sponsors to limit the access of certain beneficiaries to addictive drugs. PDP sponsors must have a utilization management tool to prevent drug addiction.

Medicare Drug Integrity Contractors may accept prescription and medical records to determine whether a beneficiary is at risk for prescription drug addiction.

Action Timeline

Action DateTypeTextSource
2016-04-01CommitteeReferred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.House committee actions
2016-03-09CommitteeReferred to the Subcommittee on Health.House committee actions
2016-03-04CommitteeReferred to the Subcommittee on Health.House committee actions
2016-03-03IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2016-03-03IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2016-03-03IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2016-03-03IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Health
See Subjects
  • Congressional oversight
  • Consumer affairs
  • Drug trafficking and controlled substances
  • Drug, alcohol, tobacco use
  • Government information and archives
  • Government studies and investigations
  • Health care quality
  • Health information and medical records
  • Health personnel
  • Health promotion and preventive care
  • Medical education
  • Medicare
  • Prescription drugs

Related Bills

See Related Bills